Ipsen S.A (IPN) | Financial Analysis & Statements
Ipsen S.A. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2024Income Metrics
Balance Sheet Metrics
Total Assets
6.9B
Total Liabilities
2.6B
Shareholders Equity
4.3B
Debt to Equity
0.60
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Ipsen S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.9B | 3.6B | 3.3B | 3.2B | 2.7B |
| Cost of Goods Sold | 750.9M | 704.4M | 571.2M | 527.7M | 438.6M |
| Gross Profit | 3.2B | 2.9B | 2.7B | 2.6B | 2.3B |
| Gross Margin % | 80.9% | 80.3% | 82.7% | 83.3% | 84.0% |
| Operating Expenses | |||||
| Research & Development | 754.0M | 686.6M | 619.3M | 445.3M | 424.4M |
| Selling, General & Administrative | 1.2B | 1.1B | 1.1B | 1.0B | 916.3M |
| Other Operating Expenses | 68.2M | 151.3M | 204.9M | 305.1M | 168.4M |
| Total Operating Expenses | 2.0B | 1.9B | 2.0B | 1.8B | 1.5B |
| Operating Income | 945.1M | 688.1M | 611.3M | 871.3M | 853.5M |
| Operating Margin % | 24.1% | 19.3% | 18.5% | 27.6% | 31.1% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | 500.0K | 100.0K |
| Interest Expense | 44.3M | 41.8M | 37.7M | 30.5M | 23.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 578.6M | 431.6M | 761.5M | 706.1M | 789.2M |
| Income Tax | 133.6M | 74.9M | 136.2M | 112.3M | 158.3M |
| Effective Tax Rate % | 23.1% | 17.4% | 17.9% | 15.9% | 20.1% |
| Net Income | 444.5M | 347.3M | 647.2M | 647.5M | 646.7M |
| Net Margin % | 11.3% | 9.7% | 19.6% | 20.5% | 23.5% |
| Key Metrics | |||||
| EBITDA | 1.6B | 1.4B | 810.0M | 1.2B | 1.1B |
| EPS (Basic) | €5.37 | €4.18 | €7.79 | €7.87 | €7.82 |
| EPS (Diluted) | €5.32 | €4.15 | €7.73 | €7.81 | €7.76 |
| Basic Shares Outstanding | 82653668 | 82751196 | 82722765 | 82413804 | 82647356 |
| Diluted Shares Outstanding | 82653668 | 82751196 | 82722765 | 82413804 | 82647356 |
Income Statement Trend
Ipsen S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.5B | 678.1M | 528.4M | 1.2B | 814.7M |
| Short-term Investments | 1.0M | 1.1M | 10.6M | 31.0M | 42.4M |
| Accounts Receivable | 786.8M | 697.2M | 631.3M | 632.5M | 564.3M |
| Inventory | 240.9M | 285.5M | 289.5M | 284.1M | 219.4M |
| Other Current Assets | 38.6M | 78.4M | 144.6M | 41.5M | 42.3M |
| Total Current Assets | 2.8B | 2.0B | 1.9B | 2.4B | 2.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 484.7M | 474.5M | 435.5M | 430.6M | 564.2M |
| Goodwill | 3.6B | 3.9B | 4.0B | 2.7B | 2.6B |
| Intangible Assets | 2.3B | 2.5B | 2.7B | 1.6B | 1.4B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 27.2M | 27.9M | 47.4M | 1.9M | 1.2M |
| Total Non-Current Assets | 4.1B | 4.4B | 4.4B | 3.2B | 3.0B |
| Total Assets | 6.9B | 6.4B | 6.3B | 5.6B | 5.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 854.2M | 854.8M | 771.4M | 647.1M | 594.7M |
| Short-term Debt | 35.3M | 37.2M | 36.4M | 31.5M | 35.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 109.9M | 143.5M | 339.0M | 442.8M | 384.9M |
| Total Current Liabilities | 1.4B | 1.5B | 1.6B | 1.3B | 1.2B |
| Non-Current Liabilities | |||||
| Long-term Debt | 831.8M | 389.6M | 337.1M | 581.8M | 657.8M |
| Deferred Tax Liabilities | 52.7M | 55.2M | 226.4M | 77.9M | 101.8M |
| Other Non-Current Liabilities | 193.8M | 207.0M | 209.5M | 63.2M | -100.0K |
| Total Non-Current Liabilities | 1.2B | 751.8M | 872.3M | 935.8M | 1.0B |
| Total Liabilities | 2.6B | 2.3B | 2.5B | 2.3B | 2.3B |
| Equity | |||||
| Common Stock | 83.8M | 83.8M | 83.8M | 83.8M | 83.8M |
| Retained Earnings | 443.5M | 345.9M | 644.4M | 648.6M | 646.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.3B | 4.2B | 3.8B | 3.3B | 2.7B |
| Key Metrics | |||||
| Total Debt | 867.1M | 426.8M | 373.5M | 613.3M | 693.1M |
| Working Capital | 1.4B | 515.8M | 271.6M | 1.1B | 725.4M |
Balance Sheet Composition
Ipsen S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 444.5M | 357.3M | 619.9M | 592.1M | 631.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 39.3M | 29.5M | 30.1M | 26.5M | 26.9M |
| Working Capital Changes | -41.2M | -113.3M | -33.4M | -68.2M | -95.1M |
| Operating Cash Flow | 482.8M | 325.3M | 723.3M | 636.2M | 581.2M |
| Investing Activities | |||||
| Capital Expenditures | -105.3M | -173.0M | -116.2M | -86.6M | -87.7M |
| Acquisitions | -343.6M | -65.2M | -915.6M | -139.3M | -11.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -391.9M | -240.4M | -1.0B | -302.3M | -2.8M |
| Financing Activities | |||||
| Share Repurchases | -67.7M | -36.5M | -39.5M | -11.3M | -36.7M |
| Dividends Paid | -116.2M | -99.6M | -99.6M | -99.3M | -82.9M |
| Debt Issuance | 510.2M | 77.0M | 24.9M | 16.0M | 686.4M |
| Debt Repayment | -33.7M | -33.0M | -2.9B | -1.3B | -966.0M |
| Financing Cash Flow | 266.4M | -123.6M | -3.0B | -1.4B | -1.4B |
| Free Cash Flow | 809.7M | 133.0M | 677.0M | 718.5M | 475.4M |
| Net Change in Cash | 357.3M | -38.7M | -3.3B | -1.1B | -787.1M |
Cash Flow Trend
Ipsen S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.83
Forward P/E
12.21
Price to Book
3.12
Price to Sales
3.43
PEG Ratio
12.21
Profitability Ratios
Profit Margin
11.29%
Operating Margin
26.10%
Return on Equity
10.44%
Return on Assets
9.60%
Financial Health
Current Ratio
1.96
Debt to Equity
22.38
Beta
0.34
Per Share Data
EPS (TTM)
€5.31
Book Value per Share
€52.47
Revenue per Share
€47.54
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| IPN | 13.4B | 30.83 | 3.12 | 10.44% | 11.29% | 22.38 |
| Boiron S.A | 446.2M | 23.15 | 1.21 | 5.22% | 3.84% | 4.90 |
| Euroapi S.A.S.U | 121.5M | 8.84 | 0.20 | -23.84% | -24.77% | 8.30 |
| AB Science S.A | 76.8M | -7.73 | - | 32.97% | 116.42% | -0.80 |
| CoreTech Limited | 1.3M | - | - | -102.42% | 137.36% | -1.03 |
Financial data is updated regularly. All figures are in the company's reporting currency.